<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39375263</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-675X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Apoptosis : an international journal on programmed cell death</Title><ISOAbbreviation>Apoptosis</ISOAbbreviation></Journal><ArticleTitle>Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10495-024-02025-5</ELocationID><Abstract><AbstractText>Mitochondria dysfunction is implicated in cell death, inflammation, and autoimmunity. During viral infections, some viruses employ different strategies to disrupt mitochondria-dependent apoptosis, while others, including SARS-CoV-2, induce host cell apoptosis to facilitate replication and immune system modulation. Given mitochondrial DNAs (mtDNA) role as a pro-inflammatory damage-associated molecular pattern in inflammatory diseases, we examined its levels in the serum of COVID-19 patients and found it to be high relative to levels in healthy donors. Furthermore, comparison of serum protein profiles between healthy individuals and SARS-CoV-2-infected patients revealed unique bands in the COVID-19 patients. Using mass spectroscopy, we identified over 15 proteins, whose levels in the serum of COVID-19 patients were 4- to 780-fold higher. As mtDNA release from the mitochondria is mediated by the oligomeric form of the mitochondrial-gatekeeper-the voltage-dependent anion-selective channel 1 (VDAC1)-we investigated whether SARS-CoV-2 protein alters VDAC1 expression. Among the three selected SARS-CoV-2 proteins, small envelope (E), nucleocapsid (N), and accessory 3b proteins, the E-protein induced VDAC1 overexpression, VDAC1 oligomerization, cell death, and mtDNA release. Additionally, this protein led to mitochondrial dysfunction, as evidenced by increased mitochondrial ROS production and cytosolic Ca<sup>2+</sup> levels. These findings suggest that SARS-CoV-2 E-protein induces mitochondrial dysfunction, apoptosis, and mtDNA release via VDAC1 modulation. mtDNA that accumulates in the blood activates the cGAS-STING pathway, triggering inflammatory cytokine and chemokine expression that contribute to the cytokine storm and tissue damage seen in cases of severe COVID-19.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shteinfer-Kuzmine</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bornshten</LastName><ForeName>Rut</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Chetrit</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Ya'acov</LastName><ForeName>Ami</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahima</LastName><ForeName>Hadas</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubin</LastName><ForeName>Ethan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mograbi</LastName><ForeName>Yosef</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>, Tel Aviv-Yafo, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shteyer</LastName><ForeName>Eyal</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoshan-Barmatz</LastName><ForeName>Varda</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6756-4340</Identifier><AffiliationInfo><Affiliation>National Institute for Biotechnology in the Negev, Beer-Sheva, Israel. vardasb@bgu.ac.il.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel. vardasb@bgu.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Apoptosis</MedlineTA><NlmUniqueID>9712129</NlmUniqueID><ISSNLinking>1360-8185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apoptosis</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">VDAC1</Keyword><Keyword MajorTopicYN="N">mtDNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375263</ArticleId><ArticleId IdType="doi">10.1007/s10495-024-02025-5</ArticleId><ArticleId IdType="pii">10.1007/s10495-024-02025-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mehta P et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Padhan K et al (2008) Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol 89(Pt 8):1960–1969</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83665-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X et al (2006) Mitochondrial location of severe acute respiratory syndrome coronavirus 3b protein. Mol Cells 21(2):186–191</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1016-8478(23)12878-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L et al (2008) Viral control of mitochondrial apoptosis. PLoS Pathog 4(5):e1000018</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000018</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: viral evasion of apoptosis. Nat Immunol 3(11):1013–1018</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1102-1013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GG et al (2001) Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. Eur J Cancer 37(13):1695–1702</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-8049(01)00182-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori I et al (2004) Virus-induced neuronal apoptosis as pathological and protective responses of the host. Rev Med Virol 14(4):209–216</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.426</ArticleId></ArticleIdList></Reference><Reference><Citation>Amara A, Mercer J (2015) Viral apoptotic mimicry. Nat Rev Microbiol 13(8):461–469</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3469</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena R et al (2023) Modulation of mitochondria by viral proteins. Life Sci 313:121271</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.121271</ArticleId></ArticleIdList></Reference><Reference><Citation>Perfettini JL et al (2005) Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ 12(Suppl 1):916–923</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401584</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16(14):R551–R560</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.06.054</ArticleId></ArticleIdList></Reference><Reference><Citation>Angajala A et al (2018) Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front Immunol 9:1605</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01605</ArticleId></ArticleIdList></Reference><Reference><Citation>Breda CNS et al (2019) Mitochondria as central hub of the immune system. Redox Biol 26:101255</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101255</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V, Mizrachi D, Keinan N (2013) Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy. Prog Mol Biol Transl Sci 117:303–334</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-386931-9.00011-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V et al (2010) VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31(3):227–285</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2010.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V, Maldonado EN, Krelin Y (2017) VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress. Cell Stress 1(1):11–36</Citation><ArticleIdList><ArticleId IdType="doi">10.15698/cst2017.10.104</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A (2020) VDAC1 at the intersection of cell metabolism, apoptosis, and diseases. Biomolecules 10(11):1485</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10111485</ArticleId></ArticleIdList></Reference><Reference><Citation>Keinan N et al (2013) The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis. Biochim Biophys Acta 1833(7):1745–1754</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2013.03.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Hail D, Shoshan-Barmatz V (2016) VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis. Biochim Biophys Acta 1863(7):1612–1623</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2016.04.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Keinan N, Tyomkin D, Shoshan-Barmatz V (2010) Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol Cell Biol 30(24):5698–5709</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00165-10</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J et al (2019) VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science 366(6472):1531–1536</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav4011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Hail D et al (2016) Novel compounds targeting the mitochondrial protein VDAC1 inhibit apoptosis and protect against mitochondrial dysfunction. J Biol Chem 291(48):24986–25003</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.744284</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domizio J et al (2022) The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 603(7899):145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamarin D et al (2005) Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1(1):e4</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0010004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani Z et al (2000) Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 74(6):2840–2846</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.6.2840-2846.2000</ArticleId></ArticleIdList></Reference><Reference><Citation>Moin SM, Panteva M, Jameel S (2007) The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem 282(29):21124–21133</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M701696200</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H, McMillan JR (2007) Gelsolin segment 5 inhibits HIV-induced T-cell apoptosis via Vpr-binding to VDAC. FEBS Lett 581(3):535–540</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.12.057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jitobaom K, Tongluan N, Smith DR (2016) Involvement of voltage-dependent anion channel (VDAC) in dengue infection. Sci Rep 6:35753</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W et al (2015) The association of receptor of activated protein kinase C 1(RACK1) with infectious bursal disease virus viral protein VP5 and voltage-dependent anion channel 2 (VDAC2) inhibits apoptosis and enhances viral replication. J Biol Chem 290(13):8500–8510</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.585687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z et al (2008) A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochim Biophys Acta 1780(12):1383–1387</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2008.07.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EA et al (2021) Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep 34(11):108863</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108863</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeman D, Fielding BC (2019) Coronavirus envelope protein: current knowledge. Virol J 16(1):69</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-019-1182-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L et al (2007) SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway. Artif Cells Blood Substit Immobil Biotechnol 35(2):237–253</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10731190601188422</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X et al (2005) Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus. Virus Res 114(1–2):70–79</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2005.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S et al (2006) Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells. Virus Res 122(1–2):20–27</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecky-Bromberg SA et al (2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81(2):548–557</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01782-06</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Hail D, Shoshan-Barmatz V (2014) Purification of VDAC1 from rat liver mitochondria. Cold Spring Harb Protoc 2014(1):94–99</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot073130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wienken CJ et al (2010) Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun 1:100</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1093</ArticleId></ArticleIdList></Reference><Reference><Citation>Deniaud A, Brenner C, Kroemer G (2004) Mitochondrial membrane permeabilization by HIV-1 Vpr. Mitochondrion 4(2–3):223–233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2004.06.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Iborra FJ, Kimura H, Cook PR (2004) The functional organization of mitochondrial genomes in human cells. BMC Biol 2:9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7007-2-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls TJ, Minczuk M (2014) In D-loop: 40 years of mitochondrial 7S DNA. Exp Gerontol 56:175–181</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2014.03.027</ArticleId></ArticleIdList></Reference><Reference><Citation>Edinger F et al (2022) Peak plasma levels of mtDNA serve as a predictive biomarker for COVID-19 in-hospital mortality. J Clin Med 11(23):7161</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11237161</ArticleId></ArticleIdList></Reference><Reference><Citation>Naryzny SN, Legina OK (2021) Haptoglobin as a biomarker. Biochem Moscow-Suppl Series B-Biomed Chem 15(3):184–198</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1990750821030069</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannen CL, Sodetz JM (2007) Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain. Mol Immunol 44(5):960–965</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2006.03.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, Heath RJ (2021) Structural and biochemical features of human serum albumin essential for eukaryotic cell culture. Int J Mol Sci 22(16):8411</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168411</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjurjo L et al (2015) AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease. J Leukoc Biol 98(2):173–184</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RU0215-074R</ArticleId></ArticleIdList></Reference><Reference><Citation>Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117(2):104–111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2005.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen JD et al (2020) C-reactive protein and its structural isoforms: an evolutionary conserved marker and central player in inflammatory diseases and beyond. Subcell Biochem 94:499–520</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-41769-7_20</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt JM, Tuder R (2012) Alpha 1 anti-trypsin: one protein, many functions. Curr Mol Med 12(7):827–835</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652412801318755</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro CD, Flajnik MF (2014) Putting J chain back on the map: how might its expression define plasma cell development? J Immunol 193(7):3248–3255</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400531</ArticleId></ArticleIdList></Reference><Reference><Citation>Budhu AS, Noy N (2002) Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 22(8):2632–2641</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.8.2632-2641.2002</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinhoff JS, Lass A, Schupp M (2021) Biological functions of RBP4 and its relevance for human diseases. Front Physiol 12:659977</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.659977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda M (2022) Transthyretin: its function and amyloid formation. Neurochem Int 155:105313</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2022.105313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Ye RD (2016) Serum amyloid A1: structure, function and gene polymorphism. Gene 583(1):48–57</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2016.02.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolska A, Reimund M, Remaley AT (2020) Apolipoprotein C-II: the re-emergence of a forgotten factor. Curr Opin Lipidol 31(3):147–153</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOL.0000000000000680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CR et al (2022) Structure genomics of SARS-CoV-2 and its omicron variant: drug design templates for COVID-19. Acta Pharmacol Sin 43(12):3021–3033</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-021-00851-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB et al (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122(5):669–682</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Q et al (2006) The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24(5):633–642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.04.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Trishna S et al (2023) Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation. Mol Ther Nucl Acids 33:713–732</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2023.07.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rurek M (2024) Mitochondria in COVID-19: from cellular and molecular perspective. Front Physiol 15:1406635</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2024.1406635</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard AJ et al (2022) Circulating, cell-free mitochondrial DNA marks disease severity in COVID-19. Am J Respir Crit Care Med 205:A2927</Citation></Reference><Reference><Citation>Fernández-Ayala DJM, Navas P, López-Lluch G (2020) Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol 142:111147</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.111147</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D et al (2021) Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. https://doi.org/10.1172/jci.insight.143299</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143299</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Aguayo JJ et al (2021) Peripheral blood mitochondrial DNA levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19. Front Cell Infect Microbiol 11:754708</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.754708</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl EJ, Yao PJ, Kapogiannis D (2023) Prediction of post-acute-sequelae of COVID-19 by cargo protein biomarkers of blood total extracellular vesicles in acute COVID-19. Am J Med 136(8):824–829</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.03.026</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17(6):363–375</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Trevino P, Velasquez M, Garcia N (2020) Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochim Biophys Acta Mol Basis Dis 1866(6):165761</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.165761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedmer A et al (2008) Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication. J Virol 82(9):4647–4655</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02198-07</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez R et al (1996) The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant. Virology 215(2):152–164</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0018</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendoza C et al (2007) Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy. AIDS 21(5):583–588</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32805e8742</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrianto MJ et al (2021) Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Microvasc Res 138:104224</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermali M et al (2020) The role of biomarkers in diagnosis of COVID-19-a systematic review. Life Sci 254:117788</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117788</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglini D et al (2022) Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front Immunol 13:857573</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.857573</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber L et al (2024) Proteomic analysis of salivary extracellular vesicles from COVID-19 patients reveals a specific anti-COVID-19 response protein signature. Int J Mol Sci 25(7):3704</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25073704</ArticleId></ArticleIdList></Reference><Reference><Citation>Quaye IK (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102(8):735–742</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trstmh.2008.04.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Moral L et al (2021) Multifaceted roles of CD5L in infectious and sterile inflammation. Int J Mol Sci 22(8):4076</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084076</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran BJ et al (2021) APOA1: a protein with multiple therapeutic functions. Curr Atheroscler Rep 23(3):11</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-021-00906-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannagan TH 3rd et al (2021) ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable. Orphanet J Rare Dis 16(1):204</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-021-01834-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazemi P et al (2023) Serum C-reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID-19: a systematic review. Immun Inflamm Dis 11(12):e1130</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.1130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali N (2020) Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol 92(11):2409–2411</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26097</ArticleId></ArticleIdList></Reference><Reference><Citation>Potempa LA et al (2020) Insights into the use of c-reactive protein as a diagnostic index of disease severity in COVID-19 Infections. Am J Trop Med Hyg 103(2):561–563</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston NR, Ashworth JJ (2018) Role of C-reactive protein at sites of inflammation and infection. Front Immunol. https://doi.org/10.3389/fimmu.2018.00754</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId></ArticleIdList></Reference><Reference><Citation>Janciauskiene S et al (2018) The multifaceted effects of alpha1-antitrypsin on neutrophil functions. Front Pharmacol 9:341</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00341</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J et al (2023) Innate and adaptive immunity to SARS-CoV-2 and predisposing factors. Front Immunol 14:1159326</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1159326</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Altamirano MMB, Kolstoe SE, Sanchez-Garcia FJ (2019) Virus control of cell metabolism for replication and evasion of host immune responses. Front Cell Infect Microbiol 9:95</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00095</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK et al (2020) Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol 319(2):C258–C267</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S et al (2021) Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol 320(1):C57–C65</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00426.2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C et al (2017) Voltage-dependent anion channel 1 interacts with ribonucleoprotein complexes to enhance infectious bursal disease virus polymerase activity. J Virol 91(16):e00584</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00584-17</ArticleId></ArticleIdList></Reference><Reference><Citation>Fongsaran C et al (2014) Voltage dependent anion channel is redistributed during Japanese encephalitis virus infection of insect cells. Sci World J 2014:976015</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/976015</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoshan-Barmatz V et al (2015) The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochim Biophys Acta 1848(10):2547–2575</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2014.10.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A et al (2022) Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology. Transl Neurodegener 11(1):58</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00329-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang E et al (2019) Preserving insulin secretion in diabetes by inhibiting VDAC1 overexpression and surface translocation in beta cells. Cell Metab 8(29):64–77</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A et al (2022) The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target. Mol Ther 30(2):726–744</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2021.06.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisthal S et al (2014) Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction. Biochim Biophys Acta 1843(10):2270–2281</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2014.03.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilansky A et al (2015) The voltage-dependent anion channel 1 mediates amyloid beta toxicity and represents a potential target for Alzheimer disease therapy. J Biol Chem 290(52):30670–30683</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.691493</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XD et al (2005) Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 102(49):17717–17722</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0508531102</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A et al (2011) The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7(3):e1001311</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001311</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantadosi CA (2020) Mitochondrial DNA, oxidants, and innate immunity. Free Radic Biol Med 152:455–461</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.01.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Thierry AR, Roch B (2020) Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy. J Clin Med 9(9):2942</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092942</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiuk K, Jablonska E, Garley M (2021) Significance of NETs formation in COVID-19. Cells 10(1):151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010151</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi MB et al (2022) Modulation of neutrophil (dys)function by Ayurvedic herbs and its potential influence on SARS-CoV-2 infection. J Ayurveda Integr Med 13(1):100424</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2021.03.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante-Silva LHA et al (2021) Neutrophils and COVID-19: the road so far. Int Immunopharmacol 90:107233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107233</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V (2018) Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 18(2):134–147</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C et al (2016) Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med 22(2):146–153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4027</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley JS, Tait SW (2020) Mitochondrial DNA in inflammation and immunity. EMBO Rep 21(4):e49799</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H et al (2022) Mitochondrial VDAC1: a potential therapeutic target of inflammation-related diseases and clinical opportunities. Cells 11(19):3174</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11193174</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W et al (2023) How the innate immune DNA sensing cGAS-STING pathway is involved in apoptosis. Int J Mol Sci 24(3):3029</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24033029</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HY et al (2022) cGAS and DDX41-STING mediated intrinsic immunity spreads intercellularly to promote neuroinflammation in SOD1 ALS model. Iscience 25(6):104404</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104404</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Zhou YH, Yang ZQ (2016) The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol Immunol 13(1):3–10</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2015.74</ArticleId></ArticleIdList></Reference><Reference><Citation>Soy M, Keser G, Atagunduz P (2021) Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 45(4):372–389</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/biy-2105-37</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>